German Biotech BioNTech Locks in $270M Series A Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace You Might Also Like Eli Lilly Quietly Works on Wearable Devices in Lab Established in 2015 November 21, 2017 Chinese Bidders Circle Johnson & Johnson’s $4B+ Diabetes Biz January 16, 2018 A Novel, Quantitative Immunohistochemistry Method Enabled By BioGenex, Inc. IHC System February 16, 2017
A Novel, Quantitative Immunohistochemistry Method Enabled By BioGenex, Inc. IHC System February 16, 2017